MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Is probable REM sleep behavior disorder a risk factor of impulsive-compulsive behaviors in Parkinson’s disease? PPMI study

M.L Fantini, J. Fedler, B. Pereira, D. Weintraub, A. Marques, F. Durif (Clermont Ferrand, France)

Meeting: MDS Virtual Congress 2020

Abstract Number: 714

Keywords: Parkinsonism

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: To assess the association of REM sleep behavior disorder (RBD) with the development of impulse compulsive behaviors (ICBs) in patients with early Parkinson’s disease (PD) using longitudinally collected data from the Parkinson’s Progression Markers Initiative.

Background: We previously observed that patients with probable RBD assessed by questionnaire (pRBD) have an increased prevalence of ICB symptoms compared with PD patients without pRBD. A recent meta-analysis including 10 studies found that RBD was associated with a more than two-fold higher risk of developing ICBs in PD. To date no longitudinal study has assessed whether RBD is a possible risk factor for the development of ICBs.

Method: 401 newly diagnosed PD patients were prospectively evaluated at month six and then annually for 5 years. Probable RBD (pRBD, not confirmed by video-polysomnography) was assessed with the RBD Screening Questionnaire and dichotomized using a cut-off value of ≥6. The association of baseline and time-dependent (TD) pRBD with the development of ICB symptoms, according to the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease (QUIP), was modeled using Cox proportional hazards regression. Models considered adjustment for age, sex, MDS-UPDRS III, geriatric depression scale (GDS), RBD medication use, total Levodopa equivalent daily dose (LEDD), Dopamine Agonist (DA) use, and antidepressant use.

Results: Baseline pRBD did not exhibit a strong association with increased risk of ICB symptoms (unadjusted hazard ratio (HR)=1.36, 95% CI (0.92, 2.02), p=0.125 and adjusted HR=1.17, 95% CI (0.77, 1.77), p=0.458). In the TD pRBD model, the risk for incident ICBs was slightly increased in pRBD patients (unadjusted HR=1.43, 95% CI (0.97, 2.10), p=0.069), but only trended towards an increase risk after adjustment for covariates (HR=1.27, 95% CI (0.84, 1.90), p=0.257). TD DA use (HR=1.64, 95% CI (1.03, 2.64), p=0.039), TD GDS (HR=1.12, 95% CI (1.06, 1.19), p<0.001), and sex (year 3: HR=2.10, 95% CI (1.20, 3.67), p=0.009; year 4: HR=3.04, 95% CI (1.37, 6.73), p=0.006; year 5: HR=4.40, 95% CI (1.51, 12.85), p=0.007) were associated with increased ICB symptom risk.

Conclusion: pRBD was not strongly associated with ICB symptoms development in contrast to DA use, GDS, and sex

To cite this abstract in AMA style:

M.L Fantini, J. Fedler, B. Pereira, D. Weintraub, A. Marques, F. Durif. Is probable REM sleep behavior disorder a risk factor of impulsive-compulsive behaviors in Parkinson’s disease? PPMI study [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/is-probable-rem-sleep-behavior-disorder-a-risk-factor-of-impulsive-compulsive-behaviors-in-parkinsons-disease-ppmi-study/. Accessed July 1, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/is-probable-rem-sleep-behavior-disorder-a-risk-factor-of-impulsive-compulsive-behaviors-in-parkinsons-disease-ppmi-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley